Akesis Pharmaceuticals

• Home
• About Us
  • Fast Facts
  • Management
  • Board of Directors
  • Scientific Advisory Board
• Pipeline
  • The Diabetes Epidemic
  • Intellectual Property
• Investor Relations
  • Stock Information
  • Akesis Team
  • Press Releases
  • SEC Filings
• Contact Us
  • Contact Us
  • Legal Information

Kevin R. Sayer

Kevin R. Sayer has served as executive vice president and chief financial officer of Specialty Labs SP (NYSE), a clinical reference laboratory services company, from April 2004 to April 2005. From 1994 to 2001, Mr. Sayer was the Chief Financial Officer of Minimed, Inc., a publicly traded medical device company focused on diabetes management. During his tenure at Minimed, Mr. Sayer managed multiple financing and strategic transactions and played a central role in the 2001 acquisition of Minimed, Inc., by Medtronic, Inc., a leader in developing solutions for diabetes. From 2001 to 2002, he co-led the integration team for the newly combined entity and assumed executive responsibilities over operations as vice president and general manager of Medtronic Minimed's External Pump and Disposable Product business unit. Mr. Sayer began his career in public accountancy and from 1983 to 1994 held various positions at Ernst & Young. He graduated from Brigham Young University in 1983 with concurrent bachelor and master degrees in Accounting and Information Systems, and is a certified public accountant.